1. Wang, Wenhao, Li, Tiewen, Xie, Zhiwen, Ruan, Yuan, Han, Bangmin. 2024. Integrating single-cell and bulk RNA sequencing data unveils antigen presentation and process-related CAFS and establishes a predictive signature in prostate cancer. In Journal of translational medicine, 22, 57. doi:10.1186/s12967-023-04807-y. https://pubmed.ncbi.nlm.nih.gov/38221616/
2. Zheng, Pengxiang, Zhang, Wenjia, Wang, Jiahong, Xu, Nan, Chen, Nannan. 2023. Bioinformatics and functional experiments reveal that MRC2 inhibits atrial fibrillation via the PPAR signaling pathway. In Journal of thoracic disease, 15, 5625-5639. doi:10.21037/jtd-23-1235. https://pubmed.ncbi.nlm.nih.gov/37969297/
3. Wang, Zihui, Li, Shaoqiang, Cai, Guannan, Hu, Jieying, Zheng, Jinping. 2024. Mendelian randomization analysis identifies druggable genes and drugs repurposing for chronic obstructive pulmonary disease. In Frontiers in cellular and infection microbiology, 14, 1386506. doi:10.3389/fcimb.2024.1386506. https://pubmed.ncbi.nlm.nih.gov/38660492/
4. Li, Lanlan, Chen, Xin, Zhang, Henglu, Wang, Min, Lu, Weiping. 2021. MRC2 Promotes Proliferation and Inhibits Apoptosis of Diabetic Nephropathy. In Analytical cellular pathology (Amsterdam), 2021, 6619870. doi:10.1155/2021/6619870. https://pubmed.ncbi.nlm.nih.gov/34012764/
5. Gopalakrishnan, Karpaka Vinayakam, Kannan, Balachander, Pandi, Chandra, Jayaseelan, Vijayashree Priyadharsini, Arumugam, Paramasivam. 2023. Prognostic and clinicopathological significance of MRC2 expression in head and neck squamous cell carcinoma. In Journal of stomatology, oral and maxillofacial surgery, 124, 101617. doi:10.1016/j.jormas.2023.101617. https://pubmed.ncbi.nlm.nih.gov/37666484/
6. Li, Ran, Ruan, Qing, Yin, Fei, Zhao, Kunchi. 2020. MiR-23b-3p promotes postmenopausal osteoporosis by targeting MRC2 and regulating the Wnt/β-catenin signaling pathway. In Journal of pharmacological sciences, 145, 69-78. doi:10.1016/j.jphs.2020.11.004. https://pubmed.ncbi.nlm.nih.gov/33357782/